IRB Study Number 17-559
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Taussig Cancer Institute
Description
The purpose of this application is to develop biorepositories encompassing the disorders:
- immune thrombocytopenia,
- warm antibody-mediated autoimmune hemolytic anemia,
- cold agglutinin disease,
- hereditary hemorrhagic telangiectasia (HHT),
- idiopathic venous thrombosis,
- thrombotic thrombocytopenic purpura (TTP),
- atypical hemolytic uremic syndrome (aHUS).
Inclusion Criteria
none
Exclusion Criteria
none
